Publication Date:
2016-05-06
Description:
SP6616 as a new Kv2.1 channel inhibitor efficiently promotes β-cell survival involving both PKC/Erk1/2 and CaM/PI3K/Akt signaling pathways Cell Death and Disease 7, e2216 (May 2016). doi:10.1038/cddis.2016.119 Authors: T T Zhou, L L Quan, L P Chen, T Du, K X Sun, J C Zhang, L Yu, Y Li, P Wan, L L Chen, B H Jiang, L H Hu, J Chen & X Shen
Electronic ISSN:
2041-4889
Topics:
Biology
,
Medicine
Permalink